Synergistic anti-fouling and bactericidal poly(ether ether ketone) surfaces via a one-step photomodification.


Journal

Materials science & engineering. C, Materials for biological applications
ISSN: 1873-0191
Titre abrégé: Mater Sci Eng C Mater Biol Appl
Pays: Netherlands
ID NLM: 101484109

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 15 01 2020
revised: 13 02 2020
accepted: 02 03 2020
entrez: 14 4 2020
pubmed: 14 4 2020
medline: 8 1 2021
Statut: ppublish

Résumé

Implants of poly(ether ether ketone) (PEEK) are gaining importance in surgical bone reconstruction of the skull. As with any implant material, PEEK is susceptible to bacterial contamination and occasionally PEEK implants were removed from patients because of infection. To address this problem, a combination of anti-fouling and bactericidal polymers is grafted onto PEEK. The originality is that anti-fouling (modified poly(ethylene glycol)) and bactericidal (quaternized poly(dimethylaminoethyl acrylate)) moieties are simultaneously and covalently grafted onto PEEK via UV photoinsertion. The functionalized PEEK surfaces are evaluated by water contact angle measurements, FTIR, XPS and AFM. Grafting of anti-fouling and bactericidal polymers significantly reduces Staphylococcus aureus adhesion on PEEK surfaces without exhibiting cytotoxicity in vitro. This study demonstrates that grafting combinations of anti-fouling and bactericidal polymers synergistically prevents bacterial adhesion on PEEK implants. This approach shows clinical relevance as grafting is rapid, does not modify PEEK properties and can be conducted on pre-formed implants.

Identifiants

pubmed: 32279824
pii: S0928-4931(20)30203-4
doi: 10.1016/j.msec.2020.110811
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Benzophenones 0
Ketones 0
Polymers 0
polyetheretherketone 31694-16-3
Polyethylene Glycols 3WJQ0SDW1A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110811

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Sytze Buwalda (S)

IBMM, University of Montpellier, CNRS, ENSCM, Montpellier, France.

Stijn Rotman (S)

AO Research Institute Davos, Clavadelerstrasse 8, 7270 Davos Platz, Switzerland; Department of Biomaterials Science and Technology, Faculty of Science and Technology, Technical Medical Centre, University of Twente, Enschede, The Netherlands.

David Eglin (D)

AO Research Institute Davos, Clavadelerstrasse 8, 7270 Davos Platz, Switzerland.

Fintan Moriarty (F)

AO Research Institute Davos, Clavadelerstrasse 8, 7270 Davos Platz, Switzerland.

Audrey Bethry (A)

IBMM, University of Montpellier, CNRS, ENSCM, Montpellier, France.

Xavier Garric (X)

IBMM, University of Montpellier, CNRS, ENSCM, Montpellier, France.

Olivier Guillaume (O)

AO Research Institute Davos, Clavadelerstrasse 8, 7270 Davos Platz, Switzerland. Electronic address: olivier.guillaume@tuwien.ac.at.

Benjamin Nottelet (B)

IBMM, University of Montpellier, CNRS, ENSCM, Montpellier, France. Electronic address: benjamin.nottelet@umontpellier.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH